Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

July 10, 2017

Biogen Appoints Amy Chevalier Efantis Vice President of Government Affairs

June 29, 2017

New Data Reaffirm Clinically Meaningful Benefit of SPINRAZA® (nusinersen) in Individuals with Spinal Muscular Atrophy Across Disease Severity

June 28, 2017

Biogen Appoints Catherine Steele Senior Vice President of Corporate Affairs

June 23, 2017

Biogen’s IMRALDI®, an Adalimumab Biosimilar Candidate Referencing Humira®, Granted Positive Opinion by Committee for Medicinal Products for Human Use

June 20, 2017

Biogen to Report Second Quarter 2017 Financial Results and Strategic Update on July 25, 2017

June 20, 2017

Biogen Appoints Ginger Gregory Executive Vice President, Chief Human Resources Officer

June 14, 2017

Real World Data Being Presented at EULAR 2017 Demonstrate Acceptance and Confirm Sustainability of Effectiveness, Safety and Adherence among Patients Switching To BENEPALI® (Etanercept Biosimilar of Biogen) from Reference Etanercept

June 14, 2017

Jean-Paul Kress Appointed EVP and President, International and Head of Global Therapeutic Operations

June 13, 2017

Biogen Announces Management Change

June 1, 2017

SPINRAZA® (Nusinersen) Approved in the European Union as First Treatment for Spinal Muscular Atrophy

Pagination

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page

Displaying 121 - 130 of 678

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us